You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils

À propos des lignes directrices

Displaying Guidelines

14 articles

An Endorsement of the 2021 Guideline on Chemotherapy in Combination with Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline

Document Status: Current
ID: GL END 5-7
Version: 3

Nov 2021

An Endorsement of the 2021 Guideline on the Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update

Document Status: In-Review
ID: GL END 3-23
Version: N/A

Oct 2021

Hepatic Arterial Infusion for Colorectal Liver Metastases

Document Status: Current
ID: GL 2-30B

May 2021

Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and the American Society of Clinical Oncology Joint Guideline

Document Status: Current
ID: GL 1-23-A

Jul 2021

Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Document Status: Current
ID: GL 4-1
Version: 2

Jan 2021

Pandemic Planning Clinical Guideline for Patients with Cancer

Document Status: Current
Version: 2

Dec 2021

Position Statements for Nursing Practice in Cancer Care

Document Status: Current
Version: 2

May 2021

Prevention and Outpatient Management of Febrile Neutropenia in Adult Cancer Patients: Clinical Practice Guideline

Document Status: Current
ID: GL-C50-27

Nov 2021

Provincial Plan for Focal Tumour Ablation Services

Document Status: Current
ID: GL-C50-32

Jan 2021

Radiation Oncology Peer Review Guidance Document

Document Status: Current
ID: GL-C50-10
Version: 1

May 2021

Recommendations Report Microwave Ablation and Cryoablation

May 2021

Systemic therapy of denosumab in altering surgical outcomes in patients with giant cell tumour of bone

Document Status: Current
ID: ES 11-13

Feb 2021